Chicago AI drug discovery shop Evozyne nabs $81M in bid to make new proteins
Chicago startup Evozyne has raised $81 million following a generative AI collaboration with Nvidia announced earlier this year.
The three-year-old startup is creating new proteins …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.